Nifty

:

25683.30

Sensex

:

83576.24

-193.55 (-0.75%)
-604.72 (-0.72%)

Login

Nifty
Sensex

:
:

25683.30
83576.24

-193.55 (-0.75%)
-604.72 (-0.72%)

Medico Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

60/99

BSE: 540937 | NSE: MEDICO

Watchlist

NSE BSE

47.95

09-Jan-2026

Open
High
Low
Previous Close

48.25
49.18
46.5
48.86

Volume
Traded Value (lacs)
52 Week High
52 Week Low

152034
7346809.82
79.83
37.18

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

398.32
35.11
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

409.96
N/A
5.96

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.51
4.28
2.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.73
22.44
8.75

PAT CAGR (%)

10 Years
5 Years
3 Years

24.47
31.26
11.70

P:E (Median)

8 Years
5 Years
3 Years

47.54
52.51
55.81

P:BV (Average)

8 Years
5 Years
3 Years

8.52
8.70
9.97

EV:EBITDA (Average)

8 Years
5 Years
3 Years

31.06
33.83
36.53

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 52.64 39.35 33.77% 38.25 30.80 24.19% 41.30 41.32 -0.05% 39.49 29.77 32.65%
Expenses 49.92 36.94 35.14% 35.43 27.99 26.58% 34.64 36.68 -5.56% 36.38 27.04 34.54%
EBITDA 2.72 2.41 12.86% 2.83 2.81 0.71% 6.66 4.65 43.23% 3.11 2.73 13.92%
EBIDTM 5.16% 6.14% 7.39% 9.12% 16.13% 11.24% 7.88% 9.18%
Other Income 1.73 0.68 154.41% 0.66 0.29 127.59% 0.29 0.58 -50.00% 1.43 0.27 429.63%
Interest 0.24 0.21 14.29% 0.28 0.18 55.56% 0.49 0.25 96.00% 0.28 0.22 27.27%
Depreciation 0.73 0.75 -2.67% 0.77 0.75 2.67% 0.77 0.74 4.05% 0.76 0.72 5.56%
PBT 3.47 2.13 62.91% 2.43 2.17 11.98% 5.70 4.25 34.12% 3.50 2.06 69.90%
Tax 0.91 0.58 56.90% 0.62 0.60 3.33% 1.36 1.15 18.26% 0.88 0.62 41.94%
PAT 2.57 1.56 64.74% 1.82 1.58 15.19% 4.34 3.10 40.00% 2.62 1.44 81.94%
PATM 4.88% 3.95% 4.75% 5.13% 10.51% 7.50% 6.63% 4.85%
EPS 0.31 0.19 63.16% 0.22 0.19 15.79% 0.52 0.37 40.54% 0.32 0.17 88.24%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 171.68 150.94 144.92 140.44 121.02 122.39 88.64 97.69 61.02 54.42 66.68 Net Sales Growth 21.55% 4.15% 3.19% 16.05% -1.12% 38.08% -9.26% 60.10% 12.13% -18.39% Cost Of Goods Sold 123.81 94.50 95.70 88.33 70.74 79.37 57.38 67.79 33.50 29.35 53.00 Gross Profit 47.87 56.44 49.22 52.11 50.29 43.02 31.25 29.90 27.52 25.07 13.68 GP Margin 27.88% 37.39% 33.96% 37.10% 41.56% 35.15% 35.25% 30.61% 45.10% 46.07% 20.52% Total Expenditure 156.37 136.52 132.01 130.96 113.69 117.15 85.80 94.93 57.54 50.41 63.03 Power & Fuel Cost - 2.92 2.55 2.47 2.29 1.91 1.83 1.73 1.42 1.05 0.00 % Of Sales - 1.93% 1.76% 1.76% 1.89% 1.56% 2.06% 1.77% 2.33% 1.93% 0% Employee Cost - 6.28 5.92 5.68 5.41 4.50 3.83 3.32 3.89 4.42 4.25 % Of Sales - 4.16% 4.09% 4.04% 4.47% 3.68% 4.32% 3.40% 6.37% 8.12% 6.37% Manufacturing Exp. - 22.10 20.88 22.36 23.00 18.02 15.00 16.03 13.73 11.00 0.00 % Of Sales - 14.64% 14.41% 15.92% 19.01% 14.72% 16.92% 16.41% 22.50% 20.21% 0% General & Admin Exp. - 3.93 2.07 1.97 2.12 2.38 2.20 1.49 1.33 1.49 5.77 % Of Sales - 2.60% 1.43% 1.40% 1.75% 1.94% 2.48% 1.53% 2.18% 2.74% 8.65% Selling & Distn. Exp. - 6.25 3.93 9.60 9.03 8.30 4.80 3.86 2.82 2.69 0.00 % Of Sales - 4.14% 2.71% 6.84% 7.46% 6.78% 5.42% 3.95% 4.62% 4.94% 0% Miscellaneous Exp. - 0.53 0.97 0.54 1.10 2.67 0.75 0.71 0.84 0.41 0.00 % Of Sales - 0.35% 0.67% 0.38% 0.91% 2.18% 0.85% 0.73% 1.38% 0.75% 0% EBITDA 15.32 14.42 12.91 9.48 7.33 5.24 2.84 2.76 3.48 4.01 3.65 EBITDA Margin 8.92% 9.55% 8.91% 6.75% 6.06% 4.28% 3.20% 2.83% 5.70% 7.37% 5.47% Other Income 4.11 3.27 2.13 4.09 2.03 1.03 2.10 1.90 0.91 0.36 0.24 Interest 1.29 1.16 0.82 0.75 0.66 0.92 1.06 0.98 1.52 1.33 0.85 Depreciation 3.03 3.03 2.88 2.72 2.22 1.65 1.66 1.51 1.00 1.05 1.18 PBT 15.10 13.50 11.33 10.10 6.48 3.70 2.22 2.18 1.87 1.99 1.87 Tax 3.77 3.41 3.04 2.86 1.67 1.11 0.58 0.60 0.65 0.06 0.74 Tax Rate 24.97% 25.26% 26.83% 28.32% 25.77% 30.00% 26.13% 27.52% 34.76% 3.55% 39.57% PAT 11.35 10.09 8.29 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 PAT before Minority Interest 11.35 10.09 8.29 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.61% 6.68% 5.72% 5.16% 3.97% 2.12% 1.84% 1.61% 2.00% 3.00% 1.69% PAT Growth 47.79% 21.71% 14.50% 50.52% 85.71% 58.90% 3.82% 28.69% -25.15% 44.25% EPS 1.37 1.22 1.00 0.87 0.58 0.31 0.20 0.19 0.15 0.20 0.14

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 62.47 52.37 43.84 36.57 32.46 29.87 28.24 26.67 16.37 14.74 Share Capital 16.60 16.60 16.60 16.60 4.15 4.15 4.15 4.15 3.20 1.60 Total Reserves 45.87 35.77 27.25 19.98 28.31 25.72 24.09 22.52 13.17 13.14 Non-Current Liabilities 0.37 1.26 2.08 2.50 5.21 4.92 2.63 2.55 10.93 4.39 Secured Loans 0.00 0.00 0.00 0.65 4.70 4.46 2.13 1.94 2.62 0.00 Unsecured Loans 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 8.22 3.70 Long Term Provisions 0.00 0.00 0.06 0.05 0.10 0.00 0.00 0.09 0.07 0.00 Current Liabilities 58.93 44.58 43.15 39.57 37.95 40.48 45.45 30.17 21.11 26.41 Trade Payables 34.71 31.51 30.99 27.10 25.35 26.40 32.52 17.52 11.88 15.36 Other Current Liabilities 6.71 3.43 1.79 1.57 4.32 6.95 2.66 2.97 1.23 0.61 Short Term Borrowings 13.59 6.50 7.85 9.06 8.11 7.12 10.27 9.69 7.90 10.10 Short Term Provisions 3.92 3.13 2.53 1.84 0.17 0.01 0.00 0.00 0.09 0.34 Total Liabilities 121.77 98.21 89.07 78.64 75.62 75.27 76.32 59.39 48.41 45.54 Net Block 21.29 21.49 21.83 18.03 15.31 12.55 12.27 6.63 6.84 7.09 Gross Block 44.09 41.34 38.80 32.39 28.89 24.36 22.43 15.37 14.57 13.77 Accumulated Depreciation 22.80 19.85 16.97 14.36 13.58 11.82 10.17 8.74 7.73 6.68 Non Current Assets 22.88 22.48 22.91 19.65 17.14 18.63 17.13 13.69 10.25 8.72 Capital Work in Progress 0.36 0.00 0.07 0.00 0.00 2.28 0.90 4.37 2.76 0.00 Non Current Investment 0.20 0.20 0.00 0.00 0.11 0.15 0.15 0.24 0.29 0.51 Long Term Loans & Adv. 0.95 0.61 0.85 1.54 1.72 3.59 3.77 2.46 0.36 1.10 Other Non Current Assets 0.08 0.18 0.16 0.07 0.00 0.06 0.05 0.00 0.00 0.01 Current Assets 98.89 75.73 66.17 59.01 58.48 56.64 59.18 45.69 38.16 36.83 Current Investments 1.45 1.36 1.27 0.00 1.06 0.00 0.00 0.00 0.00 0.00 Inventories 26.73 16.34 19.70 18.11 14.55 18.26 16.07 14.91 10.14 9.17 Sundry Debtors 57.18 49.63 36.09 30.39 27.42 23.89 29.07 17.01 18.12 19.54 Cash & Bank 1.09 0.18 0.91 2.34 2.83 1.42 0.61 0.81 0.71 0.66 Other Current Assets 12.44 0.43 0.29 0.38 12.62 13.07 13.43 12.96 9.19 7.46 Short Term Loans & Adv. 11.98 7.78 7.91 7.78 12.10 12.67 12.99 12.60 8.88 7.21 Net Current Assets 39.96 31.15 23.02 19.43 20.53 16.16 13.74 15.52 17.05 10.42 Total Assets 121.77 98.21 89.08 78.66 75.62 75.27 76.31 59.38 48.41 45.55

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 4.89 2.44 8.17 5.86 -11.31 0.97 4.94 5.10 -3.22 -3.73 PBT 13.50 11.33 10.10 6.48 3.68 2.22 2.18 1.87 1.69 1.87 Adjustment 2.44 3.53 2.71 2.52 2.57 2.14 1.86 2.15 2.46 1.94 Changes in Working Capital -7.25 -9.26 -2.15 -1.34 -16.63 -2.81 1.49 1.64 -6.56 -6.96 Cash after chg. in Working capital 8.69 5.60 10.66 7.66 -10.38 1.54 5.53 5.66 -2.42 -3.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.80 -3.17 -2.50 -1.79 -0.93 -0.54 -0.55 -0.55 -0.49 -0.58 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 -0.03 -0.04 -0.02 -0.32 0.00 Cash From Investing Activity -3.46 -2.68 -6.60 -1.76 -16.96 -3.08 -4.43 -4.98 -2.81 0.32 Net Fixed Assets -3.11 -2.47 -6.48 -3.50 -2.25 -3.31 -3.59 -2.41 -3.56 -0.30 Net Investments -0.09 -0.29 -1.27 1.17 -1.02 0.00 0.09 0.05 0.22 0.53 Others -0.26 0.08 1.15 0.57 -13.69 0.23 -0.93 -2.62 0.53 0.09 Cash from Financing Activity -0.52 -0.49 -1.82 -5.77 18.28 2.60 -0.55 -0.62 5.80 2.25 Net Cash Inflow / Outflow 0.91 -0.73 -0.25 -1.67 -9.99 0.48 -0.04 -0.50 -0.23 -1.17 Opening Cash & Equivalents 0.18 0.91 1.17 2.83 0.00 0.16 0.21 0.71 0.66 1.82 Closing Cash & Equivalent 1.09 0.18 0.91 1.17 -9.99 0.65 0.16 0.21 0.43 0.66

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 7.53 6.31 5.28 4.41 19.55 18.00 68.05 64.27 51.16 92.15 ROA 9.18% 8.85% 8.63% 6.24% 3.43% 2.15% 2.31% 2.26% 3.47% 2.78% ROE 17.58% 17.23% 18.01% 13.94% 8.31% 5.61% 5.72% 5.67% 10.47% 7.97% ROCE 21.65% 21.90% 21.88% 15.09% 10.13% 7.66% 7.79% 9.05% 9.39% 10.86% Fixed Asset Turnover 3.53 3.62 3.95 3.95 4.60 3.79 5.17 4.13 4.04 4.90 Receivable days 129.15 107.96 86.40 87.18 76.51 109.06 86.09 103.77 120.17 73.64 Inventory Days 52.07 45.38 49.13 49.25 48.92 70.69 57.88 74.02 61.63 47.46 Payable days 127.89 119.19 120.01 135.32 119.00 187.40 94.07 94.52 101.11 88.47 Cash Conversion Cycle 53.33 34.15 15.53 1.11 6.44 -7.66 49.90 83.26 80.69 32.63 Total Debt/Equity 0.22 0.13 0.18 0.29 0.46 0.46 0.48 0.47 1.18 0.94 Interest Cover 12.66 14.76 14.52 10.79 5.02 3.09 3.22 2.23 2.27 3.21

Top Investors:

l7 hitech private limited

Annual Reports:

News Update:

Medico Remedies secures supply order worth $1.78 million
7th Oct 2025, 10:42 AM

The order is for supply tablets, capsules and dry syrups
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback